Weijun Xu
- Biomedical Engineering top 2%
- Biomaterials top 1%
- Management Science and Operations Research top 1%
- Molecular Biology
- Materials Chemistry top 10%
- Topics
- Nanoplatforms for cancer theranostics (25 papers)Nanoparticle-Based Drug Delivery (21 papers)Risk and Portfolio Optimization (18 papers)
In The Last Decade
Weijun Xu
114 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Biomedical Engineering 1.2k
- Biomaterials 880
- Management Science and Operations Research 658
- Molecular Biology 491
- Materials Chemistry 436
Countries citing papers authored by Weijun Xu
This map shows the geographic impact of Weijun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Xu more than expected).
Fields of papers citing papers by Weijun Xu
This network shows the impact of papers produced by Weijun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Xu. The network helps show where Weijun Xu may publish in the future.
Co-authorship network of co-authors of Weijun Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Xu. A scholar is included among the top collaborators of Weijun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Xu. Weijun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 21 | |
| 10 | 15 | |
| 11 | 31 | |
| 12 | 58 | |
| 13 | 23 | |
| 14 | 10 | |
| 15 | 3 | |
| 16 | 36 | |
| 17 | The Fuzzy Jump-Diffusion Model to Pricing European Vulnerable Options | 7 |
| 18 | 6 | |
| 19 | 12 | |
| 20 | 1 |
About Weijun Xu
Weijun Xu is a scholar working on Management Science and Operations Research, Biomaterials and Finance, having authored 119 papers that have together received 2.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (21 papers) and Risk and Portfolio Optimization (18 papers). The work is most often cited by research in Biomaterials (880 citations), Management Science and Operations Research (658 citations) and Statistics and Probability (228 citations). Weijun Xu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Junmin Qian, Aili Suo, Jinlei Wang, Guanghui Hou, Yaping Wang, Yong‐Jun Liu, Lijie Ji, Wei-Guo Zhang, Tiantian Sun and Yu Yao. Their work appears in journals such as Nature Communications, ACS Nano and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.